OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms
Prajwal Boddu, Sa A. Wang, Naveen Pemmaraju, et al.
Leukemia Research (2018) Vol. 66, pp. 73-78
Closed Access | Times Cited: 36
Prajwal Boddu, Sa A. Wang, Naveen Pemmaraju, et al.
Leukemia Research (2018) Vol. 66, pp. 73-78
Closed Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 111
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 111
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Justin Taylor, Michael Haddadin, Vivek Upadhyay, et al.
Blood (2019) Vol. 134, Iss. 8, pp. 678-687
Open Access | Times Cited: 84
Justin Taylor, Michael Haddadin, Vivek Upadhyay, et al.
Blood (2019) Vol. 134, Iss. 8, pp. 678-687
Open Access | Times Cited: 84
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD
Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, et al.
Blood Advances (2022) Vol. 6, Iss. 10, pp. 3027-3035
Open Access | Times Cited: 30
Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, et al.
Blood Advances (2022) Vol. 6, Iss. 10, pp. 3027-3035
Open Access | Times Cited: 30
Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience
Evgeniya Angelova, L. Jeffrey Medeiros, Wei Wang, et al.
Modern Pathology (2018) Vol. 31, Iss. 11, pp. 1717-1732
Open Access | Times Cited: 45
Evgeniya Angelova, L. Jeffrey Medeiros, Wei Wang, et al.
Modern Pathology (2018) Vol. 31, Iss. 11, pp. 1717-1732
Open Access | Times Cited: 45
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases
Robert S. Ohgami, Phyu P. Aung, Alejandro A. Gru, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 147, Iss. 7, pp. 837-846
Open Access | Times Cited: 17
Robert S. Ohgami, Phyu P. Aung, Alejandro A. Gru, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 147, Iss. 7, pp. 837-846
Open Access | Times Cited: 17
Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality
Lhara Sumarriva Lezama, Karen M. Chisholm, Eugene Carneal, et al.
Histopathology (2018) Vol. 73, Iss. 5, pp. 767-776
Closed Access | Times Cited: 27
Lhara Sumarriva Lezama, Karen M. Chisholm, Eugene Carneal, et al.
Histopathology (2018) Vol. 73, Iss. 5, pp. 767-776
Closed Access | Times Cited: 27
Blastic Plasmacytoid Dendritic Cell Neoplasm
Éric Deconinck, Tony Petrella, Francine Garnache Ottou
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 491-500
Open Access | Times Cited: 21
Éric Deconinck, Tony Petrella, Francine Garnache Ottou
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 491-500
Open Access | Times Cited: 21
New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19
Whole‐genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm
Armando N. Bastidas Torres, Davy Cats, Hailiang Mei, et al.
Genes Chromosomes and Cancer (2019) Vol. 59, Iss. 5, pp. 295-308
Open Access | Times Cited: 18
Armando N. Bastidas Torres, Davy Cats, Hailiang Mei, et al.
Genes Chromosomes and Cancer (2019) Vol. 59, Iss. 5, pp. 295-308
Open Access | Times Cited: 18
Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells
Florian Renosi, Mary Callanan, Christine Lefebvre
Cancers (2022) Vol. 14, Iss. 17, pp. 4132-4132
Open Access | Times Cited: 11
Florian Renosi, Mary Callanan, Christine Lefebvre
Cancers (2022) Vol. 14, Iss. 17, pp. 4132-4132
Open Access | Times Cited: 11
Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm
Andrew A. Lane
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 589-600
Closed Access | Times Cited: 15
Andrew A. Lane
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 589-600
Closed Access | Times Cited: 15
Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm
Sophia S. Lee, Deborah McCue, Naveen Pemmaraju
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. 7, pp. 543-550
Closed Access | Times Cited: 12
Sophia S. Lee, Deborah McCue, Naveen Pemmaraju
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. 7, pp. 543-550
Closed Access | Times Cited: 12
Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling
Malini Rethnam, Darren Qiancheng Tan, Shi Hao Tan, et al.
Blood Advances (2022) Vol. 6, Iss. 18, pp. 5330-5344
Open Access | Times Cited: 8
Malini Rethnam, Darren Qiancheng Tan, Shi Hao Tan, et al.
Blood Advances (2022) Vol. 6, Iss. 18, pp. 5330-5344
Open Access | Times Cited: 8
Dendritic Cell Leukemia: a Review
Nikolaos J. Tsagarakis, Georgios Paterakis
Current Oncology Reports (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 11
Nikolaos J. Tsagarakis, Georgios Paterakis
Current Oncology Reports (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 11
Targeting CD123 in BPDCN: an emerging field
Adam J. DiPippo, Nathaniel R. Wilson, Naveen Pemmaraju
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 993-1004
Closed Access | Times Cited: 10
Adam J. DiPippo, Nathaniel R. Wilson, Naveen Pemmaraju
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 993-1004
Closed Access | Times Cited: 10
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
Audrey Bidet, Julie Quessada, Wendy Cuccuini, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 4, pp. 103421-103421
Open Access | Times Cited: 4
Audrey Bidet, Julie Quessada, Wendy Cuccuini, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 4, pp. 103421-103421
Open Access | Times Cited: 4
The great mimicker: Leukemic presentation of blastic plasmacytoid dendritic cell neoplasm with PVT1::SUPT3H fusion
Sharon Koorse Germans, Weina Chen
eJHaem (2024) Vol. 5, Iss. 1, pp. 280-282
Open Access | Times Cited: 1
Sharon Koorse Germans, Weina Chen
eJHaem (2024) Vol. 5, Iss. 1, pp. 280-282
Open Access | Times Cited: 1
Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm
Kana Sakamoto, Kengo Takeuchi
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 523-538
Closed Access | Times Cited: 6
Kana Sakamoto, Kengo Takeuchi
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 523-538
Closed Access | Times Cited: 6
Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm
Andrzej Szczepaniak, Marcin M. Machnicki, Michał Gniot, et al.
International Journal of Hematology (2019) Vol. 110, Iss. 1, pp. 102-106
Closed Access | Times Cited: 5
Andrzej Szczepaniak, Marcin M. Machnicki, Michał Gniot, et al.
International Journal of Hematology (2019) Vol. 110, Iss. 1, pp. 102-106
Closed Access | Times Cited: 5
Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic
Martin Čerňan, Tomáš Szotkowski, Michaela Kalčíková Hisemová, et al.
Neoplasma (2020) Vol. 67, Iss. 03, pp. 650-659
Open Access | Times Cited: 5
Martin Čerňan, Tomáš Szotkowski, Michaela Kalčíková Hisemová, et al.
Neoplasma (2020) Vol. 67, Iss. 03, pp. 650-659
Open Access | Times Cited: 5
Blastic plasmacytoid dendritic cell neoplasm with immunoblastoid morphology and MYC rearrangement and overexpression
Kung‐Chao Chang, Julia Yu‐Yun Lee, Kana Sakamoto, et al.
Pathology (2018) Vol. 51, Iss. 1, pp. 100-102
Closed Access | Times Cited: 4
Kung‐Chao Chang, Julia Yu‐Yun Lee, Kana Sakamoto, et al.
Pathology (2018) Vol. 51, Iss. 1, pp. 100-102
Closed Access | Times Cited: 4
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Nathaniel R. Wilson, Naveen Pemmaraju
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
Nathaniel R. Wilson, Naveen Pemmaraju
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
